Osaic Holdings
PLX icon

Osaic Holdings’s Protalix BioTherapeutics PLX Stock Holding History

Osaic Holdings’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651 Sell
300
-900
-75% -$2.23K ﹤0.01% 7378
2025
Q4 		$2.16K Buy
1,200
+500
+71% +$1.02K ﹤0.01% 7071
2025
Q3 		$1.29K Hold
700
– – ﹤0.01% 7271
2025
Q2 		$1.04K Buy
700
+300
+75% +$614 ﹤0.01% 7138
2025
Q1 		$1.02K Buy
400
+200
+100% +$478 ﹤0.01% 6809
2024
Q4 		$376 Hold
200
– – ﹤0.01% 7076
2024
Q3 		$204 Sell
200
-1,400
-88% -$1.47K ﹤0.01% 7172
2024
Q2 		$1.87K Hold
1,600
– – ﹤0.01% 6620
2024
Q1 		$2.02K Sell
1,600
-500
-24% -$747 ﹤0.01% 6466
2023
Q4 		$3.74K Sell
2,100
-100
-5% -$156 ﹤0.01% 6281
2023
Q3 		$3.65K Buy
2,200
+1,600
+267% +$2.87K ﹤0.01% 6401
2023
Q2 		$1.2K Sell
600
-1
-0.2% -$2 ﹤0.01% 6825
2023
Q1 		$1.26K Buy
601
+101
+20% +$177 ﹤0.01% 6879
2022
Q4 		$685 Buy
+500
New +$548 ﹤0.01% 7094
2021
Q2 		– Sell
-122,184
Closed -$545K – 7099
2021
Q1 		$545K Buy
+122,184
New +$569K ﹤0.01% 2787
2020
Q4 		– Sell
-100
Closed – – 6531
2020
Q3 		$0 Buy
+100
New +$362 ﹤0.01% 6360

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Osaic Holdings's PLX Position: Q1 2026 in Review

Osaic Holdings reduced its Protalix BioTherapeutics (PLX) stake by 75% in Q1 2026, selling an estimated $2.23K and leaving 300 shares worth $651. The position accounts for ﹤0.01% of the portfolio, ranked #7378.

Osaic Holdings first reported a position in PLX in Q3 2020 and has held it in 16 quarters since. The position peaked at $545K in Q1 2021. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

  • Osaic Holdings held 300 shares of Protalix BioTherapeutics worth $651 as of Q1 2026.
  • Osaic Holdings sold 900 Protalix BioTherapeutics shares in Q1 2026, an estimated $2.23K.
  • Protalix BioTherapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7378 holding.
  • Osaic Holdings first reported a position in Protalix BioTherapeutics in Q3 2020 and has held it in 16 quarters since.
  • Osaic Holdings's Protalix BioTherapeutics position peaked at $545K in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.